Home » Topics » BioWorld Science

BioWorld Science
RSS

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

June 22, 2022

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

June 22, 2022

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

June 22, 2022

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

June 22, 2022

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

June 22, 2022

KLF5 as novel therapeutic target to reduce tumorigenic GBM phenotype

June 22, 2022

[68Ga]DOTA-ECL1i PET imaging in pancreatic cancer metastasis

June 22, 2022

Use of [177Lu]Lu-CCZ01158 shows promise for the treatment of human melanoma

June 21, 2022

miR-662 revealed as a metastatis-to-bone marker in breast cancer

June 21, 2022

IND clearance for anti-CD20 armed allogeneic gamma delta T-cell therapy ACE-1831 for NHL

June 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026